Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brian Schwartz currently holds 12,500 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Schwartz has been a net buyer of CYCC stock. They have purchased $81.0K and sold $0 worth of shares.
Brian Schwartz's most recent insider trade was on Jan 29, 2024, when they sold 12,500 shares at $0.00 per share.
Brian Schwartz serves as Executive at Cyclacel Pharmaceuticals, Inc. (CYCC). They have executed 27 insider transactions totaling $81.0K over their tenure at the company.
Brian Schwartz holds the position of Executive at Cyclacel Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Brian Schwartz has shown a buying trading pattern, with $81.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Brian Schwartz was on Jan 16, 2020, when they sold $5.8M worth of ARQL shares. This transaction involved 289,838 shares at $20.00 per share.
Brian Schwartz currently owns 12,500 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brian Schwartz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brian Schwartz has 27 Form 4 filings on record as an insider at Cyclacel Pharmaceuticals, Inc..
Set alerts for Brian Schwartz and 40,000+ other insiders.